KPNA2 and urinary bladder carcinoma: Upregulated KPNA2 levels are found to be correlated with adverse outcomes of patients with clear-cell and papillary renal-cell cancer [24], bladder cancer [25], epithelial ovarian cancer [26], and so forth.